½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1394977

¼¼Æ÷Çظ® ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ¼¼°è ¿¹Ãø(2023-2032³â)

Cell Dissociation Market Size - By Product (Enzymatic Dissociation, Non-Enzymatic Dissociation), Application (Tissue Dissociation, Cell Detachment), End-user, Global Forecast, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼Æ÷Çظ® ½ÃÀå ±Ô¸ð´Â 2023-2032³â 15.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼Æ÷ ±â¹Ý Ä¡·á¿Í Àç»ýÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 È¿À²ÀûÀÎ ¼¼Æ÷ ºÐ¸® ¹æ¹ýÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ¼ö³â°£ ƯÈ÷ Áٱ⼼Æ÷ ¿¬±¸¿Í »ý¸í°øÇÐ µî ¿¬±¸°³¹ß È°µ¿ÀÌ È°¹ßÇØÁö°í ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Ä¡·á ¸ñÀûÀÇ ¼¼Æ÷ Çظ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÇÔ²² ¿¬±¸ ±â¼ú°ú ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀº º¸´Ù È¿°úÀûÀÎ ¼¼Æ÷ ºÐ¸® ¹æ¹ý °³¹ßÀÇ Çõ½ÅÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ·¹ºñŸ½º¹ÙÀÌ¿À(LevitasBio)´Â 2022³â 3¿ù °í±Þ »ý¹°ÇÐÀû ¿¬±¸¸¦ À§ÇØ Àΰ£°ú »ýÁãÀÇ Á¶Á÷ ¹× ¼¼Æ÷ »ùÇÃÀÇ Ã³¸®¸¦ Çâ»ó½ÃÅ°´Â LeviPrep(TM)°ú LeviSelect(TM) Á¦Ç°±ºÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¼¼Æ÷ ºÐ¸® ½ÃÀåÀº Á¦Ç°, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªÀ¸·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î´Â ºñÈ¿¼Ò ºÐ¸® ºÎ¹®ÀÌ 2023-2032³â 16.2%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¿ÂÈ­ÇÏ°í È¿À²ÀûÀÎ Çظ® ¹æ¹ý, ¼¼Æ÷ ½ºÆ®·¹½º °¨¼Ò, ¹Î°¨ÇÑ ¼¼Æ÷Á¾¿¡ ´ëÇÑ ÀûÇÕ¼º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ ºñÈ¿¼ÒÀû Á¢±Ù¹ýÀº ´Ù¾çÇÑ ¼¼Æ÷ ¹è¾ç ¿ëµµ ¹× ¿öÅ©Ç÷οì¿ÍÀÇ È£È¯¼ºÀ¸·Î ÀÎÇØ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù.

¼¼Æ÷ ºÐ¸® ¿ëµµ´Â ºÐ¼® ±â°£ Áß 16.5%ÀÇ CAGRÀ» º¸À̸ç Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ´Â ¼¼Æ÷ ¹è¾ç °úÁ¤¿¡¼­ È¿À²ÀûÀÌ°í ÀçÇö °¡´ÉÇÑ ¹Ú¸® ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. »ý¸í °øÇÐ, Àç»ý ÀÇÇÐ ¹× ¼¼Æ÷ ±â¹Ý Ä¡·áÀÇ ¿ëµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î º¸¸é À¯·´ÀÇ ¼¼Æ÷Çظ® »ê¾÷ ±Ô¸ð´Â 2023-2032³â ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¼¼Æ÷ ±â¹Ý ¿¬±¸ÀÇ ¹ßÀü, »ý¸í°øÇÐ ºÐ¾ßÀÇ ÀÀ¿ë ¹üÀ§ È®´ë, »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ¸·´ëÇÑ ÀÚ±Ý Áö¿øÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ À¯·´ ±¹°¡µéÀÇ Çõ½ÅÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ªÀÇ ¼¼Æ÷ ºÐ¸® ±â¼ú ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼Æ÷Çظ® ½ÃÀå ÀλçÀÌÆ®

  • ¾÷°è »óȲ
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ¼¼Æ÷ ±â¹Ý Ä¡·áÁ¦ÀÇ °³¹ß¿¡ ´ëÇÑ ÁÖ¸ñÀÇ Áõ°¡
      • ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ´ëÇÑ Àΰ¡ÀÇ Áõ°¡
      • ±â¼úÀû Áøº¸ÀÇ Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ¼ö¹ÝÇÏ´Â °íºñ¿ë
      • ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • COVID-19 ¿µÇ⠺м®
  • ±ÔÁ¦ »óȲ
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ¼¼Æ÷Çظ® ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
  • È¿¼ÒÀû Çظ®
    • Trypsin
    • Collagenase
    • Elastase
    • Papain
    • Hyaluronidase
    • DNase
    • ±âŸ È¿¼Ò
  • ºñÈ¿¼ÒÀû Çظ®
  • ±â±¸¡¤¾×¼¼¼­¸®

Á¦6Àå ¼¼Æ÷Çظ® ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : ¿ëµµº°
  • Á¶Á÷ Çظ®
  • ¼¼Æ÷Çظ®

Á¦7Àå ¼¼Æ÷Çظ® ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾»ç¿ëÀÚº°
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ¿¬±¸¡¤Çмú±â°ü
  • CRO
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ¼¼Æ÷Çظ® ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Merck KGaA
  • Thermo Fisher Scientific
  • Danaher Corp
  • STEMCELL Technologies
  • Sartorius AG
  • Miltenyi Biotec
  • PAN-Biotech
  • HiMedia Laboratories
  • F. Hoffmann-La Roche Ltd
  • S2 Genomics, Inc.
  • Nuromics
KSA 23.12.20

Cell dissociation market size is projected to record 15.3% CAGR from 2023 to 2032. The increasing demand for cell-based therapies and regenerative medicine is driving the need for several efficient cell dissociation methods. Of late, there have been rising advancements in R&D activities, particularly in stem cell research and biotechnology.

The rising prevalence of chronic diseases and the growing need for personalized medicine will drive the demand for dissociated cells for therapeutic purposes. Additionally, the continuous evolution of laboratory techniques and technologies along with the growing investments in life sciences research will also push innovations in the development of more effective dissociation methods. For instance, in March 2022, LevitasBio introduced the LeviPrep™ and LeviSelect™ product lines to enhance the processing of human and mouse tissue and cell samples for advanced biological research.

The cell dissociation market is segregated into product, application, end-user, and region.

Based on product, the industry share from the non-enzymatic dissociation segment is projected to depict 16.2% CAGR from 2023 to 2032. The growth can be attributed to the increasing demand for gentle and efficient dissociation methods, reduced cell stress, and the suitability for sensitive cell types. The non-enzymatic approach is also gaining prominence for its compatibility with various cell culture applications and workflows.

The cell detachment application segment is estimated to account for sizeable revenue share, exhibiting 16.5% CAGR throughout the analysis period. This is owing to the rising demand for efficient and reproducible detachment methods in cell culture processes. The increasing application in biotechnology, regenerative medicine, and cell-based therapies will boost the segment growth.

Regionally, the Europe cell dissociation industry size is slated to grow at rapid pace from 2023 to 2032. The growth can be ascribed to the increasing advancements in cell-based research, expanding application scope in biotechnology, and hefty funding for life sciences research. Additionally, the rising focus of several European countries on innovative healthcare solutions along with the high demand for personalized medicine will fuel the demand for cell dissociation technologies in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Global cell dissociation market 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Product trends
    • 2.1.4 Application trends
    • 2.1.5 End-user trends

Chapter 3 Cell Dissociation Market Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing focus on the development of cell-based therapeutics
      • 3.2.1.2 Increasing approval for cell-based research
      • 3.2.1.3 Rising technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with cell based research
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By application
    • 3.3.3 By end-user
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Cell Dissociation Market Estimates and Forecast, By Product, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by product
  • 5.2 Enzymatic dissociation
    • 5.2.1 Trypsin
    • 5.2.2 Collagenase
    • 5.2.3 Elastase
    • 5.2.4 Papain
    • 5.2.5 Hyaluronidase
    • 5.2.6 DNase
    • 5.2.7 Other enzymes
  • 5.3 Non-enzymatic dissociation
  • 5.4 Instruments & accessories

Chapter 6 Cell Dissociation Market Estimates and Forecast, By Application, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Tissue dissociation
  • 6.3 Cell detachment

Chapter 7 Cell Dissociation Market Estimates and Forecast, By End-user, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by end-user
  • 7.2 Pharmaceuticals and biotechnology companies
  • 7.3 Research and academic institutes
  • 7.4 CROs
  • 7.5 Other end-users

Chapter 8 Cell Dissociation Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Merck KGaA
  • 9.2 Thermo Fisher Scientific
  • 9.3 Danaher Corp
  • 9.4 STEMCELL Technologies
  • 9.5 Sartorius AG
  • 9.6 Miltenyi Biotec
  • 9.7 PAN-Biotech
  • 9.8 HiMedia Laboratories
  • 9.9 F. Hoffmann-La Roche Ltd
  • 9.10 S2 Genomics, Inc.
  • 9.11 Nuromics
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦